| 0 (0%) | 02-21 20:22 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 62.25  |
1-year : | 72.71 |
| Resists | First : | 53.29 |
Second : | 62.25 |
| Pivot price | 47.69 |
|||
| Supports | First : | 45.45 |
Second : | 40.61 |
| MAs | MA(5) : | 50.18 |
MA(20) : | 46.56 |
| MA(100) : | 44.01 |
MA(250) : | 36.24 |
|
| MACD | MACD : | 1 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 92.9 |
D(3) : | 92 |
| RSI | RSI(14): 64.4 |
|||
| 52-week | High : | 54.84 | Low : | 20.85 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ HROW ] has closed below upper band by 8.2%. Bollinger Bands are 2.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 53.37 - 53.56 | 53.56 - 53.72 |
| Low: | 49.19 - 49.43 | 49.43 - 49.62 |
| Close: | 51.63 - 52.01 | 52.01 - 52.32 |
Thu, 19 Feb 2026
How supply chain issues affect HROW stock - 2025 Earnings Surprises & Safe Swing Trade Setups - mfd.ru
Wed, 18 Feb 2026
Harrow to Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026 - Quiver Quantitative
Tue, 17 Feb 2026
Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits - markets.businessinsider.com
Tue, 17 Feb 2026
Harrow (HROW) Introduces PharmaPack to Enhance Ophthalmic Care A - GuruFocus
Tue, 17 Feb 2026
Harrow, Inc. (NASDAQ:HROW) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Mon, 16 Feb 2026
Should Harrow’s (HROW) CCO Promotion and Reaffirmed 2025 Revenue Guidance Require Action From Investors? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 37 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 15.6 (%) |
| Held by Institutions | 58.8 (%) |
| Shares Short | 5,550 (K) |
| Shares Short P.Month | 5,600 (K) |
| EPS | -0.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.26 |
| Profit Margin | -2 % |
| Operating Margin | 20.5 % |
| Return on Assets (ttm) | 4.9 % |
| Return on Equity (ttm) | -9.6 % |
| Qtrly Rev. Growth | 45.4 % |
| Gross Profit (p.s.) | 5.03 |
| Sales Per Share | 6.75 |
| EBITDA (p.s.) | 1.24 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 18 (M) |
| Levered Free Cash Flow | -56 (M) |
| PE Ratio | -400 |
| PEG Ratio | 0 |
| Price to Book value | 40.94 |
| Price to Sales | 7.7 |
| Price to Cash Flow | 109 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|